Cargando...
Advances in immunotherapeutic targets for childhood cancers: a focus on glypican-2 and B7-H3
Cancer immunotherapies have revolutionized how we can treat adult malignancies and are being translated to pediatric oncology. Chimeric antigen receptor T-cell therapy and bispecific antibodies targeting CD19 have shown success for the treatment of pediatric patients with B-cell acute lymphoblastic...
Gardado en:
| Publicado en: | Pharmacol Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8202769/ https://ncbi.nlm.nih.gov/pubmed/33992682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2021.107892 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|